31 Mar 2023
Assets666.23
Total Income443.26
EBITDA48.60
Profit After Tax-11.79
NET Worth384.73
Reserves and Surplus383.50
Total Borrowing196.21
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue483.97₹ Cr · -37.1% vs prior year
EBITDA110.31₹ Cr · -33.8% vs prior year
PAT14.23₹ Cr · -78.8% vs prior year
Assets1,193.68₹ Cr · +19.8% vs prior year
Net Worth716.06₹ Cr · +20.5% vs prior year
Borrowing207.04₹ Cr · -8.3% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2024
Assets806.02
Total Income574.72
EBITDA99.66
Profit After Tax35.13
NET Worth423.55
Reserves and Surplus408.57
Total Borrowing243.37
31 Mar 2025
Assets996.46
Total Income769.92
EBITDA166.64
Profit After Tax67.10
NET Worth594.21
Reserves and Surplus578.68
Total Borrowing225.80
30 Sep 2025
Assets1,193.68
Total Income483.97
EBITDA110.31
Profit After Tax14.23
NET Worth716.06
Reserves and Surplus704.14
Total Borrowing207.04
IPO UPDATE ALERTS
Register for IPO Updates →Track Nephrocare Health without missing an update
Register for subscription, GMP, allotment and listing notifications.